Glatiramer Acetate
Brand name: Copaxone
Rank #91 of 500 drugs by total cost
$203.6M
Total Cost
40,986
Total Claims
$203.6M
Total Cost
1,805
Prescribers
$4,968
Cost per Claim
732
Beneficiaries
43,267
30-Day Fills
$113K
Avg Cost/Provider
23
Avg Claims/Provider
About Glatiramer Acetate
Glatiramer Acetate (sold as Copaxone) was prescribed 40,986 times by 1,805 Medicare Part D providers in 2023, costing the program $203.6M. At $4,968 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 88 | Losartan Potassium (Losartan Potassium) | $213.4M | 14,466,748 |
| 89 | Oxycodone Hcl (Oxycodone Hcl) | $213.2M | 3,537,078 |
| 90 | Brexpiprazole (Rexulti) | $204.0M | 136,378 |
| 91 | Glatiramer Acetate (Copaxone) | $203.6M | 40,986 |
| 92 | Denosumab (Prolia) | $199.4M | 114,710 |
| 93 | Ticagrelor (Brilinta) | $195.8M | 293,897 |
| 94 | Lurasidone Hcl (Latuda) | $190.9M | 254,237 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology